A new prognostic index model using meta-analysis in early-stage epithelial ovarian cancer

Gynecologic Oncology

Volumn 126, Issue 3, 2012, Pages 357-363

  Park, Hyun Jong ^a   Nam, Eun Ji ^a   Rha, Sun Young ^a   Kim, Sunghoon ^a   Kim, Sang Wun ^a   Kim, Jae Wook ^b   Kim, Young Tae ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Kwandong University College of Medicine   (South Korea)

Author keywords

Early stage ovarian cancer; Meta analysis; Prediction; Prognosis factor; Prognostic index; Recurrence

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; EARLY CANCER; FEMALE; HAZARD RATIO; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MEDLINE; MODIFIED JADAD SCALE; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; NEWCASTLE OTTAWA SCALE; OVARY CARCINOMA; OVERALL SURVIVAL; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RECURRENCE FREE SURVIVAL; RISK FACTOR;

AGE FACTORS; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; NEOPLASM GRADING; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PROPORTIONAL HAZARDS MODELS;

EID: 84864404440     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.06.006     Document Type: Article

References (43)

1. P. Pisani, D.M. Parkin, F. Bray, and J. Ferlay Estimates of the worldwide mortality from 25 cancers in 1990 Int J Cancer 83 1999 18 29 (Pubitemid 29409471)
2. A.P. Heintz, F. Odicino, P. Maisonneuve, M.A. Quinn, J.L. Benedet, and W.T. Creasman Carcinoma of the ovary. FIGO 26th annual report on the results of treatment in gynecological cancer Int J Gynaecol Obstet 95 Suppl. 1 2006 S161 S192
3. G.S. Richardson, R.E. Scully, N. Nikrui, and J.H. Nelson Jr. Common epithelial cancer of the ovary (2) N Engl J Med 312 1985 415 424
4. J.C. van Houwelingen, W.W. ten Bokkel Huinink, M.E. van der Burg, A.T. van Oosterom, and J.P. Neijt Predictability of the survival of patients with advanced ovarian cancer J Clin Oncol 7 1989 769 773 (Pubitemid 19145599)
5. B. Lund, P. Williamson, H.C. van Houwelingen, and J.P. Neijt Comparison of the predictive power of different prognostic indices for overall survival in patients with advanced ovarian carcinoma Cancer Res 50 1990 4626 4629 (Pubitemid 20230403)
6. S. Teramukai, K. Ochiai, H. Tada, and M. Fukushima PIEPOC: a new prognostic index for advanced epithelial ovarian cancer - Japan Multinational Trial Organization OC01-01 J Clin Oncol 25 2007 3302 3306 (Pubitemid 47325616)
7. Z. Margaliot, and K.C. Chung Systematic reviews: a primer for plastic surgery research Plast Reconstr Surg 120 2007 1834 1841 (Pubitemid 350306678)
8. R. Pazdur Endpoints for assessing drug activity in clinical trials Oncologist 13 Suppl. 2 2008 19 21
9. D. Lebwohl, A. Kay, W. Berg, J.F. Baladi, and J. Zheng Progression-free survival: gaining on overall survival as a gold standard and accelerating drug development Cancer J 15 2009 386 394
10. M. Oremus, C. Wolfson, A. Perrault, L. Demers, F. Momoli, and Y. Moride Interrater reliability of the modified Jadad quality scale for systematic reviews of Alzheimer's disease drug trials Dement Geriatr Cogn Disord 12 2001 232 236 (Pubitemid 32217854)
11. D.A. Cook, R. Hatala, R. Brydges, B. Zendejas, J.H. Szostek, and A.T. Wang Technology-enhanced simulation for health professions education: a systematic review and meta-analysis JAMA 306 2011 978 988
12. M. Kogo, A. Kano, Y. Kiuchi, K. Mitamura, and K. Yoneyama Prognostic index for survival in patients after treatment for primary hepatocellular carcinoma Dig Dis Sci 52 2007 2444 2451 (Pubitemid 47246472)
13. G. Bolis, N. Colombo, S. Pecorelli, V. Torri, S. Marsoni, and C. Bonazzi Adjuvant treatment for early epithelial ovarian cancer: results of two randomised clinical trials comparing cisplatin to no further treatment or chromic phosphate (32P). G.I.C.O.G.: Gruppo Interregionale Collaborativo in Ginecologia Oncologica Ann Oncol 6 1995 887 893
14. C. Tropé, J. Kaern, T. Hogberg, V. Abeler, B. Hagen, and G. Kristensen Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument Ann Oncol 11 2000 281 288 (Pubitemid 30214664)
15. I. Vergote, J. De Brabanter, A. Fyles, K. Bertelsen, N. Einhorn, and P. Sevelda Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma Lancet 357 2001 176 182 (Pubitemid 32108089)
16. J.B. Trimbos, I. Vergote, G. Bolis, J.B. Vermorken, C. Mangioni, and C. Madronal Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial J Natl Cancer Inst 95 2003 113 125 (Pubitemid 36193260)
17. N. Colombo, D. Guthrie, S. Chiari, M. Parmar, W. Qian, and A.M. Swart International Collaborative Ovarian Neoplasm trial 1: a randomized trial of adjuvant chemotherapy in women with early-stage ovarian cancer J Natl Cancer Inst 95 2003 125 132 (Pubitemid 36193261)
18. A. Maggioni, P. Benedetti Panici, T. Dell'Anna, F. Landoni, A. Lissoni, and A. Pellegrino Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis Br J Cancer 95 2006 699 704 (Pubitemid 44373484)
19. J.K. Chan, C. Tian, B.J. Monk, T. Herzog, D.S. Kapp, and J. Bell Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study Cancer 112 2008 2202 2210 (Pubitemid 351628630)
20. W.D. Kang, H.S. Choi, and S.M. Kim Value of serum CA125 levels in patients with high-risk, early stage epithelial ovarian cancer Gynecol Oncol 116 2010 57 60
21. I.A. Skírnisdóttir, B. Sorbe, K. Lindborg, and T. Seidal Prognostic impact of p53, p27, and C-MYC on clinicopathological features and outcome in early-stage (FIGO I-II) epithelial ovarian cancer Int J Gynecol Cancer 21 2011 236 244
22. A. Bamias, A. Karadimou, N. Soupos, M. Sotiropoulou, F. Zagouri, and D. Haidopoulos Prognostic factors for early-stage epithelial ovarian cancer, treated with adjuvant carboplatin/paclitaxel chemotherapy: a single institution experience Gynecol Oncol 123 2011 37 42
23. T. Sugiyama, T. Kamura, J. Kigawa, N. Terakawa, Y. Kikuchi, and T. Kita Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy Cancer 88 2000 2584 2589 (Pubitemid 30331967)
24. S. Yamamoto, A. Kasajima, M. Takano, N. Yaegashi, H. Fujiwara, and K. Kuzuya Validation of the histologic grading for ovarian clear cell adenocarcinoma: a retrospective multi-institutional study by the Japan Clear Cell Carcinoma Study Group Int J Gynecol Pathol 30 2011 129 138
25. S.M. Lenhard, A. Bufe, C. Kümper, P. Stieber, D. Mayr, and L. Hertlein Relapse and survival in early-stage ovarian cancer Arch Gynecol Obstet 280 2009 71 77
26. G.J. Rustin, R.C. Bast Jr., G.J. Kelloff, J.C. Barrett, S.K. Carter, and P.D. Nisen Use of CA-125 in clinical trial evaluation of new therapeutic drugs for ovarian cancer Clin Cancer Res 10 2004 3919 3926 (Pubitemid 38697628)
27. I. Jacobs, D. Oram, J. Fairbanks, J. Turner, C. Frost, and J.G. Grudzinskas A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer Br J Obstet Gynaecol 97 1990 922 929 (Pubitemid 20340625)
28. M.M. Leitao Jr., J. Boyd, A. Hummer, N. Olvera, C.D. Arroyo, and E. Venkatraman Clinicopathologic analysis of early-stage sporadic ovarian carcinoma Am J Surg Pathol 28 2004 147 159 (Pubitemid 38124722)
29. J.K. Chan, D. Teoh, J.M. Hu, J.Y. Shin, K. Osann, and D.S. Kapp Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers Gynecol Oncol 109 2008 370 376
30. A.W. Kennedy, C.V. Biscotti, W.R. Hart, and K.D. Webster Ovarian clear cell adenocarcinoma Gynecol Oncol 32 1989 342 349 (Pubitemid 19074926)
31. P.J. Timmers, A.H. Zwinderman, I. Teodorovic, I. Vergote, and J.B. Trimbos Clear cell carcinoma compared to serous carcinoma in early ovarian cancer: same prognosis in a large randomized trial Int J Gynecol Cancer 19 2009 88 93
32. Y.Y. Lee, T.J. Kim, M.J. Kim, H.J. Kim, T. Song, and M.K. Kim Prognosis of ovarian clear cell carcinoma compared to other histological subtypes: a meta-analysis Gynecol Oncol 122 2011 541 547
33. J.K. Chan, M. Zhang, J.M. Hu, J.Y. Shin, K. Osann, and D.S. Kapp Racial disparities in surgical treatment and survival of epithelial ovarian cancer in United States J Surg Oncol 97 2008 103 107 (Pubitemid 351169035)
34. M.T. Redaniel, A. Laudico, M.R. Mirasol-Lumague, A. Gondos, G.L. Uy, and J.A. Toral Ovarian cancer survival population differences: a high resolution study comparing Philippine residents, and Filipino-Americans and Caucasians living in the US BMC Cancer 9 2009 340
35. M. Terplan, E.J. Smith, and S.M. Temkin Race in ovarian cancer treatment and survival: a systematic review with meta-analysis Cancer Causes Control 20 2009 1139 1150
36. C. Chastang, D. Byar, and S. Piantadosi A quantitative study of the bias in estimating the treatment effect caused by omitting a balanced covariate in survival models Stat Med 7 1988 1243 1255 (Pubitemid 19018454)
37. Cochrane Handbook for Systematic Reviews of Interventions http://www.cochrane.org/training/cochrane-handbook
38. E.P. Navarese, M. Koziński, T. Pafundi, F. Andreotti, A. Buffon, and S.D. Servi Practical and updated guidelines on performing meta-analyses of non-randomized studies in interventional cardiology Cardiol J 18 2011 3 7
39. M.W. Russo How to review a meta-analysis Gastroenterol Hepatol 3 2007 637 642 (Pubitemid 47461022)
40. N. Freemantle, and T. Strack Real-world effectiveness of new medicines should be evaluated by appropriately designed clinical trials J Clin Epidemiol 63 2010 1053 1058
41. P.D. Home How can observational trials inform and improve clinical practice? Diabetes Res Clin Pract 88 Suppl. 1 2010 S1 S2
42. S.L. Silverman From randomized controlled trials to observational studies Am J Med 122 2009 114 120
43. I. Shrier, J.F. Boivin, R.J. Steele, R.W. Platt, A. Furlan, and R. Kakuma Should meta-analyses of interventions include observational studies in addition to randomized controlled trials? A critical examination of underlying principles Am J Epidemiol 166 2007 1203 1209 (Pubitemid 350022749)